In contrast to drug-targeted therapy, immunotherapy uses the body’s own immune system to attack cancer cells and includes immune checkpoint inhibitors such as programmed cell death 1 (PDCD1; also known as PD-1) and cytotoxic T-lymphocyte associated protein 4 (CTLA4) inhibitors (10). The gene discussed is CTLA4; the disease is cancer.